ArticleCureus2026
Diffuse Myocardial Metastases From Neuroendocrine Malignancy.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neuroendocrine tumors of the thymus (NETT) are rare anterior mediastinal tumors known for their aggressive metastatic potential. This case report describes a middle-aged patient who presented with dyspnea. Multimodality imaging, including computed tomography (CT), transthoracic echocardiography (TTE), cardiac magnetic resonance imaging (MRI), and Gallium-68 DOTATATE positron emission tomography (PET), was used to suggest a diagnosis of NETT, which was confirmed by biopsies of the mediastinal mass and myocardium. Chemotherapy and octreotide were initiated, and follow-up DOTATATE PET demonstrated a partial treatment response. In the absence of appropriate clinical history and ancillary imaging findings, such as an adjacent mediastinal mass, the cardiac imaging features observed in this case (biventricular enlargement with patchy, diffuse myocardial hyperenhancement) may present a diagnostic dilemma because they are nonspecific. This case highlights the importance of distinguishing myocardial metastasis from hypertrophic cardiomyopathy (HCM) and infiltrative cardiomyopathy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.